Richard H Peters

This inventor holds 22 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Anti-Estrogenic Steroids. Top assignees: Sri International, Stanford Research Institute, Other. Active years: 1976-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard H Peters. Retrieved from https://idiyas.com/inventor/richard-h-peters

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 7

Forward Citations = 284(Granted Patents)

Location History:

Fresno, CA (US) (1981 - 1985)
San Jose, CA (US) (1976 - 2010)

Company Filing History:

Stanford Research Institute

patents

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2010

Loading Chart...

Areas of Expertise:

Anti-Estrogenic Steroids

Therapeutic Steroids

Pharmaceutical Compositions

Estrone Sulfatase Inhibitors

Progestins

Stereoisomers

Steroid Inhibitors

19-Norpregna Compounds

Estranes

Loweralkyl Homologs

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7772218 - Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one (2010-08-10),

2. 6784170 - Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one (2004-08-31),

3. 6747018 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2004-06-08),

4. 6548491 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2003-04-15),

5. 6503896 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2003-01-07),

6. 6455517 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2002-09-24),

7. 6281205 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2001-08-28),

8. 6054446 - Anti-estrogenic steroids, and associated pharmaceutical compositions and (2000-04-25),

9. 6046186 - Estrone sulfamate inhibitors of estrone sulfatase, and associated (2000-04-04),

10. 5861388 - Steroid inhibitors of estrone sulfatase and associated pharmaceutical (1999-01-19),

11. 5763432 - Steriod inhibitors of estrone sulfatase and associated pharmaceutical (1998-06-09),

12. 5478862 - 15,16-seco-19-nor progestins (1995-12-26),

13. 5321044 - 15,16-seco-19-nor progestins (1994-06-14),

14. 5116865 - 15,16-seco-19-nor progestins (1992-05-26),

15. 5116830 - Stereoisomerically pure 17.alpha.-ethynyl-estra-2-en-17.beta.-ol and the (1992-05-26),

Title: **Richard H Peters: Innovator in Therapeutic Steroid Synthesis**

Introduction

Richard H Peters, an accomplished inventor based in San Jose, CA, holds an impressive portfolio of 22 patents. His innovative work primarily focuses on the synthesis of therapeutic steroids, which have significant implications in the medical field, particularly in treating various disorders such as prostatic cancer.

Latest Patents

Among his latest contributions, Peters has developed methods for the synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one. Notably, he has worked on the synthesis of steroids such as 3-hydroxy-7α-methyl-21-[2'-methoxy-4′-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate, known as SR 16234, and its analogs. These innovative processes involve utilizing 21-hydroxy-19-norpregna-4-en-3-one as a starting material or intermediate, which can be efficiently produced from estrone-3-methyl ether. Importantly, several intermediates developed during these syntheses have therapeutic applications, especially for treating prostate disorders.

Career Highlights

Throughout his career, Peters has demonstrated expertise in pharmacology and organic chemistry. His tenure at Sri International is a testament to his commitment to advancing the field of therapeutic steroid development. His research has led to multiple patents that reflect his innovative approaches to steroid synthesis and applications in medicine.

Collaborations

Richard H Peters has collaborated with notable colleagues such as Masato Tanabe and Wan-Ru Chao. These partnerships have enriched his research endeavors and contributed to the successful development of new therapeutic agents, showcasing the importance of collaboration in driving innovation.

Conclusion

Richard H Peters is a prominent inventor whose contributions to the synthesis of therapeutic steroids have made a significant impact in the field of medicine. With 22 patents to his name, his work with anti-estrogenic compounds and related therapies continues to inspire advancements in treatment options for serious health conditions such as prostatic cancer. His collaborations and research highlight the ongoing importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.